Home > Authors > Soumonty Kanungo

Soumonty Kanungo

  • Wockhardt not to supply bulk drugs to European Union

    The UK drug regulator's recently updated statement of non-compliance has included all active substances manufactured at Wockhardt's Chikalthana facility following the company's decision to end supply of active pharmaceutical ingredients (APIs) to the European Union (EU) markets.

    Thursday, 22 January 2015 - 7:10am
  • Indian tourists may skip Switzerland if franc spurts further

    Travel agents say they may opt for Germany, Austria

    Tuesday, 20 January 2015 - 6:25am
  • MNCs recall drugs made in Indian plants

    Three multinational companies, including Actavis recently, have recalled medicines made in their Indian units in last six months; many local companies have recalled drugs in recent times.

    Monday, 19 January 2015 - 7:10am
  • MNCs beat Indian drug firms in December sales

    Multinational pharma companies, which were hit the most by price control in 2013, are back on a roll in India. They have outperformed the Indian drug makers in October-December quarter sales following a yearly price increase taken by all pharma companies during the April-June quarter. ...

    Friday, 16 January 2015 - 7:41am
  • States to get drug price watchdog

    The units PMRUs will provide technical assistance to state drug controllers and NPPA in monitoring notified prices, violation of provisions in DPCO, pricing compliance and availability of drugs. It will also help the regulator in monitoring price movement of scheduled and non-scheduled...

    Friday, 9 January 2015 - 7:30am
  • UK regulator eases restrictions on Wockhardt plant

    Full clearance to Chikalthana unit yet to come; co seeking clarity on products it can start exporting to UK

    Thursday, 8 January 2015 - 7:30am
  • Pharma set for healthy run this year

    Pharma stocks can see an upside of 15-18% this year in line with earnings momentum on the back of strong prospects expected in the US and India markets. According to analysts, most pharma stocks will outperform as growth in the sector is intact. Abhishek Sharma, pharma analyst, IIFL, said, “The...

    Thursday, 1 January 2015 - 7:30am
  • US drug approvals, focus on R&D to drive pharma sector in 2015

    Pace of approvals in the US could hasten in the coming months of New Year, helping pharma companies with improved growth rates and margins

    Friday, 26 December 2014 - 7:15am
  • Tourism, hospitality will reap the benefits of government steps in 2015

    Till November this year, the number of foreign tourist arrivals has gone up by 7.1% to 65.8 lakh; decision to extend e-visa facility for tourists from 43 countries, including the US, Australia, Israel and Japan is viewed as a significant move

    Thursday, 25 December 2014 - 7:20am
  • Carlson plans to introduce hotel brands Quorvus Collection and Radisson Red in India

    International hospitality brand Carlson Rezidor is mulling introducing two more brands, Quorvus and Radisson Red, in India. The company plans to have around 4-5 Radisson Red properties in India by 2020. The hotel major currently operates five brands – Radisson Blu, Radisson, Park Plaza, Country...

    Monday, 22 December 2014 - 7:45am